We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Denies PMRS Petition to Deny Chronic-Use Opioid NDAs
FDA Denies PMRS Petition to Deny Chronic-Use Opioid NDAs
The FDA denied a petition from Pharmaceutical Manufacturing Research Services (PMRS) asking the agency to set a higher standard for NDAs for abuse-deterrent opioids for treatment of chronic pain.